Test Directory
Protein S Activity
Justification
Reduced protein S may be seen in warfarin therapy, pregnancy, use of oral contraceptives, DIC, acute thrombosis, HIV, nephrotic syndrome, liver disease and L-asparaginase chemotherapy. Congenital or acquired deficiency of protein S is also a risk factor for venous thromboembolism (VTE).
Protein S is a Vitamin K-dependent plasma protein synthesized in the liver. Activated protein S acts as a cofactor to protein C, greatly potentiating its anticoagulant function.
STAT: < 24 hours (7 days a week)
Clot-based
Draw Tube: Blue Top
Sample Type: Citrated Plasma
Specimen Requirements
| Sample Type | Volume Required | Minimum Volume | Stability | |
|---|---|---|---|---|
| PREFERRED | Citrated Plasma | 1mL | 0.5mL | Frozen (-20C): 2 weeks Frozen (-80C): 6 months |
| ALTERNATIVE | - | - | - | - |
| REJECTION CRITERIA | Thawed in transit, refrozen or clotted sample |
| SPECIAL INSTRUCTIONS | - |
General Information
| METHODOLOGY | Clot-based |
| STAT TAT | < 24 hours (7 days a week) |
| STAT TAT Performance | > 90% of results released in 24 hours 7 days a week |
| ROUTINE TAT | < 3 days (M-F) |
| ALTERNATIVE NAMES | PS |
| DESCRIPTION | The principle of the Protein S Activity assay is based upon the cofactor activity of protein S which enhances the anticoagulant action of activated protein C. This enhancement is reflected by the prolongation of the clotting time of a system enriched with factor Va which is a physiological substrate for activated protein C. |
| LIMITATIONS | - |
| NORMAL RANGE | 68-136% |
| ASSOCIATED TESTING | - |
| REFERENCES | - |
| SAMPLE REPORT | Upon request |
| NEW YORK STATE APPROVED | Yes |
Test Codes
| ORDER CODE | P3100 |
| CPT CODE | 85306 |
| LOINC CODE | 27822-6 |